Definitive Contract 36C26226C0197
- Not listed
- The Department of Veterans Affairs (VA) awarded a firm-fixed price purchase order contract to Biocartis US Inc. for the procurement of MSI (Microsatellite Instability) testing reagents for the Greater Los Angeles VA Healthcare System. The contract, valued at $60,479.12, has a period of performance of 1 year and the products must be compatible with the Biocartis Idyla System. There was no set-aside designation for this full and open competition solicitation, which was issued as a Request for...
- This is a firm-fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) to Biocartis US Inc., a foreign-owned, for-profit organization. The contract is for the procurement of MSI (microsatellite instability) testing reagent cartridges for the VA Greater Los Angeles Healthcare System's Pathology and Laboratory Medicine Services Department. The contract has a ceiling value of $62,361.00 and a performance period of January 31, 2027. This contract was awarded through...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 awarded a $297,941 firm-fixed price purchase order to Biocartis US Inc. to provide microsatellite instability equipment. The solicitation sought an automated single gene molecular system capable of performing assays on tissue samples in under two minutes and identifying single genes including MSI. The equipment will be utilized at the VA Greater Los Angeles Healthcare System to perform MSI...
- Veterans Integrated Service Network 16 (VA) awarded a purchase order to Veterans Healthcare Supply Solutions, Inc., a Service-Disabled Veteran-Owned Small Business, for $274,830 in microsatellite instability reagents, with an award date of April 10, 2024. The order covers Funding Option Period 2 from October 1, 2025 through September 30, 2026 under Executive Order 14398. Work is performed in Jacksonville, Florida. The reagents support MSI testing on the Biocartis Idylla system at Central...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 7, awarded a firm fixed-price purchase order valued at $116,829.71 to Biocartis US Inc. for cancer marker testing services utilizing the company's Idylla molecular diagnostic platform. The contract, posted as a special notice on March 1, 2022, and awarded on May 16, 2022, requires performance through May 15, 2027, at the contractor's facility in Jersey City, New Jersey. This award was issued through full and open...
- The U.S. Department of Veterans Affairs (VA) awarded a $441,828.09 firm-fixed-price purchase order contract to Biocartis US Inc. for the provision of Idylla instruments, EGFR assays, and related supplies and reagents. The contract is for the Veterans Integrated Service Network 22 (VISN 22) and has an ultimate completion date of August 25, 2026. The contract does not have a set-aside designation. Biocartis US Inc. is the prime contractor, and the contract does not indicate any major...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 (VA - VHA VISN 22) awarded a $373,415 firm-fixed-price purchase order to Veterans Healthcare Supply Solutions Inc. to provide reagents and consumables for next generation sequencing to support myeloid and DNA solid tumor testing at the VA Greater Los Angeles Healthcare System. The solicitation sought these products to perform over 50 genes of DNA and RNA testing using specified Ion Torrent...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16 (VA - VHA VISN 16) awarded a $247,199.70 firm fixed price purchase order to Biocartis US Inc. for IDYLLA services. The contract has a one-year period of performance from July 1, 2023 through June 30, 2024. Biocartis US Inc. will deliver its IDYLLA molecular diagnostic testing platform and services from its location in Jersey City, New Jersey to support the VA - VHA VISN 16's healthcare...
- This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 22 to Veterans Healthcare Supply Solutions, Inc., a Service-Disabled Veteran-Owned Small Business (SDVOSB). The contract, valued at $304,440.00, is for the delivery of myeloid test kits to support the molecular oncology testing program at the VA Greater Los Angeles Healthcare System. The contract has an ultimate completion date of April 17, 2023. The original...
- This firm fixed price purchase order was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 6 to Veterans Healthcare Supply Solutions Inc. for the delivery of BioCartis Idylla reagent assays. The solicitation requested quotes for six assay types totaling 142 packs from BioCartis US Inc. to be delivered to the Asheville VA Medical Center. Valued at $105,100, the contract has a period of performance of October 1, 2022 through...
Veterans Integrated Service Network 22 awarded a $403,764 definitive contract to Biocartis US Inc. for MSI testing reagent cartridges on a reagent rental basis on May 22, 2026, under firm fixed-price pricing with no set-aside. The solicitation, posted May 11, 2026, requested fully automated assay capabilities for the Pathology and Laboratory Medicine department at VA Greater Los Angeles Healthcare System, requiring qualitative detection of microsatellite instability mutations across seven loci (ACVR2A, BTBD7, DIDO1, MRE11, RYR3, SEC31A, and SULF2) on FFPE tissue sections with results within approximately 150 minutes. The reagent rental structure includes reagent cartridge kits, Idylla Instrument and Console, and annual preventative maintenance. Place of performance is the Veterans Administration facility in Los Angeles, California. The contract runs from May 22, 2026, through May 21, 2031, with a base year and four one-year option periods. Annual requirements comprise 50 packages of six MSI assay reagent cartridges, one Idylla Console unit, and three Idylla Instrument units. NAICS code 325413; PSC 6550. This is an unrestricted commercial products acquisition under FAR Part 12 issued through full and open competition.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
6550--Molecular Oncology-MSI Testing | 36C26226Q0730 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 | Solicitation 1/1 | 5/11/26, 2:05 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $76.1k | 5/18/26 |